블로그

• Gastric Cancer News Food and Drug Administration (FDA) approved the use of Sutent (SU 11248, sunitinib malate) for the treatment A patient information sheet has been published on the FDA Web site.[1] Sutent is an oral kinase inhibitor blog.naver.com · 2006.11.26